{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:01:43Z","timestamp":1790647303906,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suzhou Medical Basic and Clinical Research Foundation","award":["SYWD2025385"],"award-info":[{"award-number":["SYWD2025385"]}]},{"name":"the Suzhou Science and Technology Development Program","award":["SKY2023053"],"award-info":[{"award-number":["SKY2023053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00889-y","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:25:40Z","timestamp":1783394740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD13 identifies S100A4+ immunosuppressive monocytes and predicts temozolomide benefit in glioblastoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Dong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, et al. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780.","journal-title":"Pharmacol Res"},{"key":"889_CR2","doi-asserted-by":"crossref","unstructured":"Alban TJ, et al. Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight. 2018;3.","DOI":"10.1172\/jci.insight.122264"},{"key":"889_CR3","doi-asserted-by":"crossref","unstructured":"Lakshmanachetty S, Cruz-Cruz J, Hoffmeyer E, Cole AP, Mitra SS. New insights into the multifaceted role of myeloid-derived suppressor cells (MDSCs) in high-grade gliomas: from metabolic reprogramming, immunosuppression, and therapeutic resistance to current strategies for targeting MDSCs. Cells. 2021;10.","DOI":"10.3390\/cells10040893"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1002\/jcp.29713","volume":"235","author":"A Al-Hakami","year":"2020","unstructured":"Al-Hakami A, et al. Cytokine physiognomies of MSCs from varied sources confirm the regenerative commitment post-coculture with activated neutrophils. J Cell Physiol. 2020;235:8691\u2013701.","journal-title":"J Cell Physiol"},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol. 2016;37:208\u201320.","journal-title":"Trends Immunol"},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"aad3018","DOI":"10.1126\/science.aad3018","volume":"352","author":"DF Quail","year":"2016","unstructured":"Quail DF, et al. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science. 2016;352:aad3018.","journal-title":"Science"},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21:938\u201345.","journal-title":"Nat Med"},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/ijc.28622","volume":"134","author":"PL Raber","year":"2014","unstructured":"Raber PL, et al. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer. 2014;134:2853\u201364.","journal-title":"Int J Cancer"},{"key":"889_CR9","doi-asserted-by":"crossref","unstructured":"Groth C, et al. Blocking migration of polymorphonuclear myeloid-derived suppressor cells inhibits mouse melanoma progression. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13040726"},{"key":"889_CR10","doi-asserted-by":"publisher","first-page":"e126853","DOI":"10.1172\/jci.insight.126853","volume":"4","author":"L Sun","year":"2019","unstructured":"Sun L, et al. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 2019;4:e126853.","journal-title":"JCI Insight"},{"key":"889_CR11","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1096\/fj.201902467R","volume":"34","author":"ME Shaul","year":"2020","unstructured":"Shaul ME, et al. Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis. FASEB J. 2020;34:4204\u201318.","journal-title":"FASEB J"},{"key":"889_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","volume":"41","author":"H Liu","year":"2023","unstructured":"Liu H, et al. Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma. Cancer Cell. 2023;41:693\u2013710.","journal-title":"Cancer Cell"},{"key":"889_CR13","doi-asserted-by":"publisher","unstructured":"Pu J, et al. Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance. Discov Oncol. 2025;16. https:\/\/doi.org\/10.1007\/s12672-025-02567-3.","DOI":"10.1007\/s12672-025-02567-3"},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ccell.2024.12.006","volume":"43","author":"J Gao","year":"2025","unstructured":"Gao J, et al. Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding. Cancer Cell. 2025;43:122\u2013e143128.","journal-title":"Cancer Cell"},{"key":"889_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","volume":"32","author":"V Kumar","year":"2017","unstructured":"Kumar V, et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell. 2017;32:654\u2013e668655.","journal-title":"Cancer Cell"},{"key":"889_CR16","doi-asserted-by":"publisher","first-page":"560211","DOI":"10.3389\/fonc.2020.560211","volume":"10","author":"W Fu","year":"2020","unstructured":"Fu W, et al. CyTOF Analysis Reveals a Distinct Immunosuppressive Microenvironment in IDH Mutant Anaplastic Gliomas. Front Oncol. 2020;10:560211.","journal-title":"Front Oncol"},{"key":"889_CR17","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1182\/blood-2006-06-032599","volume":"109","author":"LC Jacobsen","year":"2007","unstructured":"Jacobsen LC, Theilgaard-Monch K, Christensen EI, Borregaard N. Arginase 1 is expressed in myelocytes\/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood. 2007;109:3084\u20137.","journal-title":"Blood"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.4049\/jimmunol.1500959","volume":"195","author":"C Cimen Bozkus","year":"2015","unstructured":"Cimen Bozkus C, Elzey BD, Crist SA, Ellies LG, Ratliff TL. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity. J Immunol. 2015;195:5237\u201350.","journal-title":"J Immunol"},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4110\/in.2017.17.5.298","volume":"17","author":"CW Hong","year":"2017","unstructured":"Hong CW. Current Understanding in Neutrophil Differentiation and Heterogeneity. Immune Netw. 2017;17:298\u2013306.","journal-title":"Immune Netw"},{"key":"889_CR20","doi-asserted-by":"crossref","unstructured":"Garratt LW. Current understanding of the neutrophil transcriptome in health and disease. Cells. 2021;10.","DOI":"10.3390\/cells10092406"},{"key":"889_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41422-025-01145-0","volume":"35","author":"W 21 Liu","year":"2025","unstructured":"21 Liu W, et al. Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression. Cell Res. 2025;35:588\u2013606. https:\/\/doi.org\/10.1038\/s41422-025-01145-0.","journal-title":"Cell Res"},{"key":"889_CR22","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1084\/jem.20181952","volume":"216","author":"J Mastio","year":"2019","unstructured":"Mastio J, et al. Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs. J Exp Med. 2019;216:2150\u201369.","journal-title":"J Exp Med"},{"key":"889_CR23","doi-asserted-by":"publisher","unstructured":"Abdelfattah N, et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022;13. https:\/\/doi.org\/10.1038\/s41467-022-28372-y.","DOI":"10.1038\/s41467-022-28372-y"},{"key":"889_CR24","doi-asserted-by":"publisher","unstructured":"Shi T, et al. CHI3L3\u207a immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastases. Cancer Cell. 2025;43:1937-1957.e11. https:\/\/doi.org\/10.1016\/j.ccell.2025.07.007.","DOI":"10.1016\/j.ccell.2025.07.007"},{"key":"889_CR25","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.4049\/jimmunol.1300742","volume":"191","author":"Y Li","year":"2013","unstructured":"Li Y, et al. Induction of functional human macrophages from bone marrow promonocytes by M-CSF in humanized mice. J Immunol. 2013;191:3192\u20139.","journal-title":"J Immunol"},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.immuni.2020.07.017","volume":"53","author":"HQ Dinh","year":"2020","unstructured":"Dinh HQ, et al. Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow. Immunity. 2020;53:319\u201334.","journal-title":"Immunity"},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"889_CR28","first-page":"1169","volume":"41","author":"J Ye","year":"2019","unstructured":"Ye J, et al. TROAP regulates prostate cancer progression via the WNT3\/survivin signalling pathways. Oncol Rep. 2019;41:1169\u201379.","journal-title":"Oncol Rep"},{"key":"889_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.21037\/atm-22-1112","volume":"10","author":"H 29 Liu","year":"2022","unstructured":"29 Liu H, Zhou Q, Xu X, Du Y, Wu J. ASPM and TROAP gene expression as potential malignant tumor markers. Ann Transl Med. 2022;10:586. https:\/\/doi.org\/10.21037\/atm-22-1112.","journal-title":"Ann Transl Med"},{"key":"889_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco G, et al. RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. Cell Rep. 2019;26:1627\u2013e16401627.","journal-title":"Cell Rep"},{"key":"889_CR31","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","volume":"12","author":"R Grieshaber-Bouyer","year":"2021","unstructured":"Grieshaber-Bouyer R, et al. The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments. Nat Commun. 2021;12:2856.","journal-title":"Nat Commun"},{"key":"889_CR32","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ccell.2024.08.008","volume":"42","author":"M Lad","year":"2024","unstructured":"Lad M, et al. Glioblastoma induces the recruitment and differentiation of dendritic-like hybrid neutrophils from skull bone marrow. Cancer Cell. 2024;42:1549\u2013e15691516. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.008.","journal-title":"Cancer Cell"},{"key":"889_CR33","doi-asserted-by":"crossref","unstructured":"Czader M. Clinical flow cytometry in molecular genetic pathology. Mol Genet Pathol. 2013.","DOI":"10.1007\/978-1-4614-4800-6_10"},{"key":"889_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41418-021-00848-2","volume":"29","author":"M Hu","year":"2022","unstructured":"Hu M, et al. CD63 acts as a functional marker in maintaining hematopoietic stem cell quiescence through supporting TGF\u03b2 signaling in mice. Cell Death Differ. 2022;29:178\u201391.","journal-title":"Cell Death Differ"},{"key":"889_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imr.13176","volume":"314","author":"BB Antuamwine","year":"2023","unstructured":"Antuamwine BB, et al. N1 versus N2 and PMN- MDSC: A critical appraisal of current concepts on tumor- associated neutrophils and new directions for human oncology. Immunol Rev. 2023;314:250\u201379.","journal-title":"Immunol Rev"},{"key":"889_CR36","doi-asserted-by":"publisher","unstructured":"Cai B, et al. N2-polarized neutrophils guide bone mesenchymal stem cell recruitment and initiate bone regeneration: a missing piece of the bone regeneration puzzle. Adv Sci. 2021;8. https:\/\/doi.org\/10.1002\/advs.202100584.","DOI":"10.1002\/advs.202100584"},{"key":"889_CR37","doi-asserted-by":"publisher","first-page":"553967","DOI":"10.3389\/fimmu.2020.553967","volume":"11","author":"L Wu","year":"2020","unstructured":"Wu L, Zhang XH. Tumor-Associated Neutrophils and Macrophages-Heterogenous but Not Chaotic. Front Immunol. 2020;11:553967.","journal-title":"Front Immunol"},{"key":"889_CR38","doi-asserted-by":"publisher","unstructured":"Wang P, et al. Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1\u03b1\/HIF2\u03b1 regulation. Cell Death Dis. 2025;16. https:\/\/doi.org\/10.1038\/s41419-025-07617-w.","DOI":"10.1038\/s41419-025-07617-w"},{"key":"889_CR39","doi-asserted-by":"publisher","unstructured":"Zhang W, et al. CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitro. BMC Cancer. 2024;24. https:\/\/doi.org\/10.1186\/s12885-024-12113-z.","DOI":"10.1186\/s12885-024-12113-z"},{"issue":"19","key":"889_CR40","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1158\/0008-5472.CAN-17-1294","volume":"77","author":"K-H Chow","year":"2017","unstructured":"Chow K-H, et al. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. Cancer Res. 2017;77(19):5360\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1294.","journal-title":"Cancer Res"},{"key":"889_CR41","doi-asserted-by":"publisher","unstructured":"Gouaz\u00e9-Andersson V, et al. FGFR1 inhibition by pemigatinib enhances radiosensitivity in glioblastoma stem cells through S100A4 downregulation. Cells. 2025;14. https:\/\/doi.org\/10.3390\/cells14181427.","DOI":"10.3390\/cells14181427"},{"key":"889_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nm.3560","volume":"20","author":"H Qin","year":"2014","unstructured":"Qin H, et al. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nat Med. 2014;20:676\u201381.","journal-title":"Nat Med"},{"key":"889_CR43","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wilt E, Lu X. Human isogenic cell line models for neutrophils and myeloid-derived suppressor cells. Int J Mol Sci. 2020;21:7755.","DOI":"10.3390\/ijms21207709"},{"key":"889_CR44","doi-asserted-by":"publisher","first-page":"e1258504","DOI":"10.1080\/2162402X.2016.1258504","volume":"6","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarinoma. OncoImmunology. 2017;6:e1258504.","journal-title":"OncoImmunology"},{"key":"889_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jcmm.13927","volume":"23","author":"F Erhart","year":"2019","unstructured":"Erhart F, et al. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+\/CD133+\/ITGA6+\/CD36\u2009+\u2009signature. J Cell Mol Med. 2019;23:281\u201392.","journal-title":"J Cell Mol Med"},{"key":"889_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13045-018-0666-5","volume":"11","author":"DN Petrusca","year":"2018","unstructured":"Petrusca DN, et al. Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis. J Hematol Oncol. 2018;11:123.","journal-title":"J Hematol Oncol"},{"key":"889_CR47","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41590-018-0237-5","volume":"19","author":"B Knier","year":"2018","unstructured":"Knier B, et al. Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity. Nat Immunol. 2018;19:1341\u201351.","journal-title":"Nat Immunol"},{"key":"889_CR48","doi-asserted-by":"publisher","unstructured":"Stefanescu C, Van Gogh M, Roblek M, Heikenwalder M, Borsig L. TGF\u03b2 signaling in myeloid cells promotes lung and liver metastasis through different mechanisms. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.765151.","DOI":"10.3389\/fonc.2021.765151"},{"key":"889_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/iid3.85","volume":"3","author":"K Weatherly","year":"2015","unstructured":"Weatherly K, et al. Functional profile of S100A4-deficient T cells. Immun Inflamm Dis. 2015;3:431\u201344. https:\/\/doi.org\/10.1002\/iid3.85.","journal-title":"Immun Inflamm Dis"},{"key":"889_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s43018-025-01097-9","volume":"7","author":"PM Moreno-Sanchez","year":"2026","unstructured":"Moreno-Sanchez PM, Rezaeipour M, Inderberg EM, Platten M, Golebiewska A. Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity. Nat Cancer. 2026;7:29\u201342. https:\/\/doi.org\/10.1038\/s43018-025-01097-9.","journal-title":"Nat Cancer"},{"key":"889_CR51","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1182\/blood-2015-06-655043","volume":"126","author":"T Moroy","year":"2015","unstructured":"Moroy T, Vassen L, Wilkes B, Khandanpour C. From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation. Blood. 2015;126:2561\u20139.","journal-title":"Blood"},{"key":"889_CR52","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez JM, et al. CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110. J Hematol Oncol. 2020;13. https:\/\/doi.org\/10.1186\/s13045-020-00865-7.","DOI":"10.1186\/s13045-020-00865-7"},{"key":"889_CR53","doi-asserted-by":"publisher","unstructured":"Deeson MA, Chua CYX, Grattoni A. Overcoming intratumoral transport barriers: advances in local immunotherapy delivery platforms. Adv Drug Deliv Rev. 2026;235. https:\/\/doi.org\/10.1016\/j.addr.2026.115888.","DOI":"10.1016\/j.addr.2026.115888"},{"key":"889_CR54","doi-asserted-by":"publisher","unstructured":"Ballest\u00edn P, et al. Understanding the toxicity profile of approved ADCs. Pharmaceutics. 2025;17. https:\/\/doi.org\/10.3390\/pharmaceutics17020258.","DOI":"10.3390\/pharmaceutics17020258"},{"key":"889_CR55","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/procel\/pwaf012","volume":"16","author":"S Liu","year":"2025","unstructured":"Liu S, et al. Targeting IRG1 in tumor-associated macrophages for cancer therapy. Protein Cell. 2025;16:478\u201383. https:\/\/doi.org\/10.1093\/procel\/pwaf012.","journal-title":"Protein Cell"},{"key":"889_CR56","doi-asserted-by":"publisher","unstructured":"Bai L, et al. FMRP silencing via siRNA lipid nanoparticles to reprogram the tumor microenvironment and enhance anti-PD-1 efficacy in triple-negative breast cancer. Mater Today Bio. 2025;33. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102075.","DOI":"10.1016\/j.mtbio.2025.102075"},{"key":"889_CR57","doi-asserted-by":"publisher","unstructured":"Billing LJ, et al. Precision targeting of myeloid cells via peptide dendrimer-lipid nanocarriers: a novel platform for potent cancer immunotherapies. Adv Sci. 2025;12. https:\/\/doi.org\/10.1002\/advs.202514417.","DOI":"10.1002\/advs.202514417"},{"key":"889_CR58","doi-asserted-by":"publisher","unstructured":"Anderluzzi G, et al. A novel aminopeptidase N\/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins. Cell Mol Life Sci. 2024;81. https:\/\/doi.org\/10.1007\/s00018-023-05102-1.","DOI":"10.1007\/s00018-023-05102-1"},{"key":"889_CR59","doi-asserted-by":"publisher","unstructured":"Monnier M, et al. Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation\/polarization processes between human and mouse macrophages. J Immunother Cancer. 2022;10. https:\/\/doi.org\/10.1136\/jitc-2022-005560.","DOI":"10.1136\/jitc-2022-005560"},{"key":"889_CR60","doi-asserted-by":"publisher","unstructured":"Moreno-Sanchez PM, et al. Humanized glioblastoma patient-derived orthotopic xenografts recreate a locally immunosuppressed human immune ecosystem amenable to immunotherapeutic modulation. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.11.20.689484.","DOI":"10.1101\/2025.11.20.689484"},{"key":"889_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.17.654526","author":"J Takei","year":"2025","unstructured":"Takei J, et al. Exploring the immune environment of glioblastoma through single-cell RNA sequencing in humanized mouse models. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.05.17.654526.","journal-title":"bioRxiv"},{"key":"889_CR62","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731\u20138.","journal-title":"J Immunol"},{"key":"889_CR63","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.immuni.2022.07.008","volume":"55","author":"K Medetgul-Ernar","year":"2022","unstructured":"Medetgul-Ernar K, Davis MM. Standing on the shoulders of mice. Immunity. 2022;55:1343\u201353.","journal-title":"Immunity"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00889-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:48Z","timestamp":1790645088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00889-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00889-y","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"186"}}